Group 1 - The company, Global Medical (02666), announced the issuance of the second phase of renewable corporate bonds by its wholly-owned subsidiary, China Global Leasing Co., Ltd. [1] - The total principal amount of the bonds issued is RMB 550 million, with a fixed interest rate of 2.35% [1] - The bonds were issued on August 8, 2025, with a basic term of 3 years, and the issuer has the right to exercise the renewal option at the end of the basic term and at the end of each renewal cycle [1]

Core Viewpoint - Global Medical (02666.HK) has received approval from the China Securities Regulatory Commission to publicly issue a maximum of RMB 2 billion in domestic perpetual corporate bonds aimed at qualified investors, with a remaining quota of RMB 1.2 billion as of the announcement date [1] Group 1 - The bond issuance will be conducted in tranches, with the total principal amount for this issuance not exceeding RMB 850 million [1] - The basic term of the corporate bond is set at 3 years, with the issuer having the option to extend the term by one repricing cycle or fully redeem the bond at the end of the agreed term and each repricing cycle [1] - The bond includes options for the issuer to extend the term, defer interest payments, and redeem the bond [1] Group 2 - The interest rate for the first cycle will remain fixed and will be determined through a book-building process at the time of subscription, with the coupon rate set as the initial benchmark rate plus an initial spread [1] - Subsequent cycles will see the coupon rate adjusted to the current benchmark rate plus the initial spread plus an additional 300 basis points [1] - The net proceeds from this bond issuance will be used by the issuer to supplement operational funds [1]